HOME >> BIOLOGY >> NEWS
Novel Liver Steroid Slows Brain Tumor Growth

Laboratory studies at Johns Hopkins have dramatically confirmed the power of a chemical discovered from the liver of sharks to slow the formation of new blood vessels destined to feed brain cancers as well as other tumors.

Squalamine, previously shown to have antibiotic and anti-cancer activity, inhibited the growth of brain cancers called gliomas implanted in the flanks of rats by disabling blood vessel growth, or angiogenesis, say the authors of the studies, published in the July 1 issue of the journal Cancer Research.

"Our results suggest that squalamine may be well suited for humans in the treatment of brain tumors and other diseases characterized by and dependent on new blood vessel growth," says Henry Brem, M.D., director of neurosurgical oncology at Hopkins and senior author of the study. "It dramatically slowed blood vessel formation without damaging healthy cells or embryonic development."

Named for the shark genus Squalus, squalamine was discovered in 1992 by scientists who founded Magainin Pharmaceuticals, which processes the chemical and funded the Hopkins studies. Squalamine is the first of a new class of naturally occurring molecules, aminosterols, under development for human therapies.

Squalamine is isolated from the tissues of the dog shark. It blocks or interferes with several steps in a cascade of events involved in blood vessel growth. Based on the Hopkins laboratory work, it is currently in Phase I clinical trials at the University of Texas (San Antonio) and at Georgetown Cancer Center.

In laboratory tests, squalamine proved to be as effective as the chemotherapeutic agent carmustine in slowing the growth of gliomas, the most common and deadly brain tumors, in rats. Squalamine also slowed the growth of new blood vessels caused by tumors in rabbits' eyes, slowed the growth of endothelial cells in rat brain tissue and constricted the tiny blood vessels in chick embryos. The latter ves
'"/>

Contact: Karen Infeld
kinfeld@jhmi.jhu
(410)955-1534
Johns Hopkins Medical Institutions
1-Jul-1998


Page: 1 2

Related biology news :

1. Novel IBD therapeutic approaches reported from Washington Univ., Barcelona, LSU at APS meeting
2. Novel therapeutic bortezomib moves to phase II trial in lung cancer patients
3. Novel approaches to current cellular therapies continue progress toward disease prevention
4. Novel therapies show promise against myeloid leukemia
5. Novel sensors help clear the air
6. Fox Chase Cancer Center study: Novel DNA-repair gene mutation can cause resistance to cancer drugs
7. Novel proteins designed that block inflammation regulator associated with rheumatoid arthritis
8. Novel therapeutic target identified in fight against Rheumatoid Arthritis
9. Novel bacterium detoxifies chlorinated pollutants
10. Novel flu vaccine shows promise in mice
11. Novel gene therapy on the horizon, says Brenner Childrens Hospital pediatrician

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/14/2019)... TORONTO (PRWEB) , ... August 14, 2019 , ... Join ... live session on Tuesday, September 10, 2019 at 1pm EDT to learn ... stratification and effective management. , NAFLD is the most common diffuse liver disease, ...
(Date:8/14/2019)... ... August 14, 2019 , ... Gateway Genomics , ... children, announces inclusion in the 38th annual Inc. 500|5000 list of fastest ... To qualify, companies must have been founded and generating revenue by March 31, 2015. ...
(Date:8/14/2019)... ... ... Julie Reck of Veterinary Medical Center of Fort Mill has recently begun providing ... her own geriatric Australian Shepherd, Simon, was treated in June 2019 for osteoarthritis in his ... body was weak, and he struggled to play fetch and other games with his family. ...
Breaking Biology News(10 mins):
(Date:9/11/2019)... ... September 09, 2019 , ... Suvoda LLC ... and drug supply chain management, today announced its new technology partnership with ... , “The integration between Veeva Vault EDC and our IRT will enable sponsors ...
(Date:9/8/2019)... YORK (PRWEB) , ... September 04, 2019 , ... ... New York Academy of Sciences announced today the three Winners and six ... outstanding postdoctoral scientists from academic research institutions across New York, New Jersey, and ...
(Date:8/29/2019)... ... August 29, 2019 , ... Scientists have mapped the ... hope will ultimately help protect the multibillion-dollar grape industry that produces juice, jelly, ... faculty and alumni sequenced the microbiome found within tumors of grapevines afflicted with ...
(Date:8/27/2019)... ... 27, 2019 , ... Modality Solutions , an Inc. ... Consulting Engineer, Robert Battista, to Senior Consulting engineer. , In his new leadership ... new engineers as well as the creation of additional business opportunities and cutting-edge ...
Breaking Biology Technology:
Cached News: